Frequencies for measure_name variable in measure_dates dataset : Measure_Name | Freq. Percent Cum. ----------------------------------------+----------------------------------- 30-Day All-Cause Mortality Following .. | 1 0.62 0.62 30-Day All-Cause Unplanned Readmissio.. | 1 0.62 1.23 30-Day Hospital-Wide All-Cause Unplan.. | 1 0.62 1.85 30-Day Readmission Rate Following Ele.. | 1 0.62 2.47 ACS Participation data | 1 0.62 3.09 AHRQ_PSI_90_Score | 1 0.62 3.70 Abdomen CT - Use of Contrast Material | 1 0.62 4.32 Accidental puncture or laceration Rate | 1 0.62 4.94 Acute Ischemic Stroke (STK) 30-Day Mo.. | 1 0.62 5.56 Acute Myocardial Infarction (AMI) 30-.. | 3 1.85 7.41 Acute Myocardial Infarction (AMI) 30-.. | 1 0.62 8.02 Acute Myocardial Infarction (AMI) 30-.. | 1 0.62 8.64 Adjuvant Chemotherapy Colon Cancer | 1 0.62 9.26 Adjuvant Hormonal Therapy | 1 0.62 9.88 Admit Decision Time to ED Departure T.. | 1 0.62 10.49 Alcohol Use Screening | 1 0.62 11.11 Anticoagulation Therapy for Atrial Fi.. | 1 0.62 11.73 Antithrombotic Therapy By End of Hosp.. | 1 0.62 12.35 Appropriate Follow-Up Interval for No.. | 1 0.62 12.96 Aspirin at Arrival | 1 0.62 13.58 Assessed for Rehabilitation | 1 0.62 14.20 Assessment of Patient Experience of C.. | 1 0.62 14.81 CAUTI_Score | 1 0.62 15.43 CLABSI_Score | 1 0.62 16.05 Cardiac imaging for preoperative risk.. | 1 0.62 16.67 Catheter Associated Urinary Tract Inf.. | 2 1.23 17.90 Catheter Associated Urinary Tract Inf.. | 1 0.62 18.52 Catheter Associated Urinary Tract Inf.. | 1 0.62 19.14 Central Line Associated Bloodstream I.. | 2 1.23 20.37 Central Line Associated Bloodstream I.. | 1 0.62 20.99 Central Line Associated Bloodstream I.. | 1 0.62 21.60 Central Venous Catheter-Related Blood.. | 1 0.62 22.22 Chronic Obstructive Pulmonary Disease.. | 1 0.62 22.84 Chronic Obstructive Pulmonary Disease.. | 2 1.23 24.07 Clostridium Difficile (C.Diff) | 1 0.62 24.69 Colonoscopy Interval for Patients wit.. | 1 0.62 25.31 Combination Chemotherapy Breast Cancer | 1 0.62 25.93 Combined SSI | 2 1.23 27.16 Complication Rate Following Elective .. | 2 1.23 28.40 Complication/patient safety for selec.. | 3 1.85 30.25 Death among surgical inpatients with .. | 1 0.62 30.86 Discharged on Antithrombotic Therapy | 1 0.62 31.48 Discharged on Statin Medication | 1 0.62 32.10 Domain_1_Score | 1 0.62 32.72 Domain_2_Score | 1 0.62 33.33 Elective Delivery | 1 0.62 33.95 Emergency Department Volume | 1 0.62 34.57 Evaluation of LVS Function | 1 0.62 35.19 Fibrinolytic Therapy Received Within .. | 1 0.62 35.80 Fibrinolytic Therapy Received Within .. | 2 1.23 37.04 Fibrinolytic Therapy Received within .. | 1 0.62 37.65 Follow-up after Hospitalization for M.. | 1 0.62 38.27 Follow-up after Hospitalization for M.. | 1 0.62 38.89 HCAHPS Linear Score for each measure | 1 0.62 39.51 HCAHPS Measures | 2 1.23 40.74 HCAHPS Summary Star Rating | 1 0.62 41.36 Head CT or MRI Scan Results for Acute.. | 1 0.62 41.98 Healthcare Personnel Influenza Vaccin.. | 1 0.62 42.59 Heart Failure (HF) 30-Day Mortality R.. | 3 1.85 44.44 Heart Failure (HF) 30-Day Readmission.. | 1 0.62 45.06 Heart Failure (HF) 30-Day Readmissions | 1 0.62 45.68 Home Management Plan of Care (HMPC) D.. | 1 0.62 46.30 Hospital Acquired Potentially-Prevent.. | 1 0.62 46.91 Hospital Outpatient Volume Data on Se.. | 1 0.62 47.53 Hours of physical-restraint use | 1 0.62 48.15 Hours of seclusion | 1 0.62 48.77 Iatrogenic pneumothorax, adult Rate | 1 0.62 49.38 Influenza Immunization | 3 1.85 51.23 Initial Antibiotic Selection for CAP .. | 3 1.85 53.09 Intensive Care Unit Venous Thromboemb.. | 1 0.62 53.70 Left without being seen | 1 0.62 54.32 MRI Lumbar Spine for Low Back Pain | 1 0.62 54.94 MRSA Bacteremia | 1 0.62 55.56 Mammography Follow-up Rates | 1 0.62 56.17 Median Time from ED Arrival to ED Dep.. | 1 0.62 56.79 Median Time from ED Arrival to ED Dep.. | 1 0.62 57.41 Median Time from ED Arrival to Provid.. | 1 0.62 58.02 Median Time to ECG | 1 0.62 58.64 Median Time to Fibrinolysis | 1 0.62 59.26 Median Time to Pain Management for Lo.. | 1 0.62 59.88 Median Time to Transfer to Another Fa.. | 1 0.62 60.49 Participation in a Systematic Clinica.. | 1 0.62 61.11 Participation in a Systematic Clinica.. | 1 0.62 61.73 Participation in a Systematic Databas.. | 1 0.62 62.35 Patient satisfaction survey results | 1 0.62 62.96 Patients discharged on multiple antip.. | 1 0.62 63.58 Patients discharged on multiple antip.. | 1 0.62 64.20 Perioperative Pulmonary Embolism (PE).. | 1 0.62 64.81 Pneumonia 30-Day Mortality Rate | 3 1.85 66.67 Pneumonia 30-Day Readmission Rate | 1 0.62 67.28 Pneumonia 30-Day Readmissions | 1 0.62 67.90 Post-discharge continuing care plan c.. | 1 0.62 68.52 Post-discharge continuing care plan t.. | 1 0.62 69.14 Postoperative Hip Fracture Rate | 1 0.62 69.75 Postoperative Sepsis Rate | 1 0.62 70.37 Postoperative wound dehiscence Rate | 1 0.62 70.99 Pressure Ulcer Rate | 1 0.62 71.60 Primary PCI Received Within 90 Minute.. | 1 0.62 72.22 Prophylactic Antibiotic Received With.. | 1 0.62 72.84 Prophylactic Antibiotic Selection for.. | 3 1.85 74.69 Prophylactic Antibiotics Discontinued.. | 3 1.85 76.54 Risk-Standardized Payment Associated .. | 1 0.62 77.16 Risk-Standardized Payment Associated .. | 1 0.62 77.78 Risk-Standardized Payment Associated .. | 1 0.62 78.40 SSI - Abdominal Hysterectomy | 3 1.85 80.25 SSI - Colon Surgery | 3 1.85 82.10 SSI_Score | 1 0.62 82.72 Safe Surgery Checklist Use | 2 1.23 83.95 Simultaneous use of brain Computed To.. | 1 0.62 84.57 Spending per Hospital Patient with Me.. | 3 1.85 86.42 Stroke (STK) 30-Day Readmission Rate | 1 0.62 87.04 Stroke Education | 1 0.62 87.65 Surgery Patients Who Received Appropr.. | 3 1.85 89.51 Surgery Patients on Beta-Blocker Ther.. | 3 1.85 91.36 The Ability for Providers with HIT to.. | 1 0.62 91.98 Thorax CT - Use of Contrast Material | 1 0.62 92.59 Thrombolytic Therapy | 1 0.62 93.21 Total_HAC_Score | 1 0.62 93.83 Tracking Clinical Results between Vis.. | 1 0.62 94.44 Urinary Catheter Removed on Postoper.. | 2 1.23 95.68 Urinary Catheter Removed on Postopera.. | 1 0.62 96.30 Use of an Electronic Health Record | 1 0.62 96.91 Venous Thromboembolism (VTE) Prophyla.. | 1 0.62 97.53 Venous Thromboembolism Patients Recei.. | 1 0.62 98.15 Venous Thromboembolism Patients with .. | 1 0.62 98.77 Venous Thromboembolism Prophylaxis | 1 0.62 99.38 Venous Thromboembolism Warfarin Thera.. | 1 0.62 100.00 ----------------------------------------+----------------------------------- Total | 162 100.00 by Jean Roth , jroth@nber.org , 15 Nov 2016